Diagnosis, subdiagnosis | Number | Sex (F/M) | Age (years) Median (range) | CD25brightCD4+ in PB (%) Median (range) | CD25brightCD4+ in SF (%) Median (range) | Fold increase, SF/PBa Median (range)b |
---|---|---|---|---|---|---|
Spondyloarthropathies | 36 | 20/16 | 46 (21–83) | 0.7 (0.2–2.9) | 2.7 (0.4–9.1) | 4.8 (0.7–20.7)*** |
   PsA | 26 | 14/12 | 50 (24–83) | 0.6 (0.2–2.9) | 2.6 (1.0–9.1) | 4.7 (0.9–20.7) |
   SpAc | 10 | 6/4 | 33 (21–58) | 1.2 (0.4–2.4) | 3.4 (0.4–6.8) | 5.0 (0.7–17.6) |
   JIA | 21 | 18/3 | 30 (18–50) | 0.4 (0.1–1.8) | 3.7 (0.3–6.7) | 6.7 (3.1–16.3)*** |
Rheumatoid arthritis | 135 | 107/28 | 57 (22–85) | 0.7 (0.04–2.9) | 2.3 (0.2–19.9) | 3.7 (0.4–56.8)*** |
   RF+ | 109 | 88/21 | 57 (25–81) | 0.7 (0.04–2.9) | 2.3 (0.3–19.9) | 3.5 (0.4–56.8) |
   RF- | 26 | 19/7 | 56 (22–85) | 0.9 (0.2–2.4) | 2.4 (0.7–19.7) | 4.3 (0.6–19.9) |
Healthy controls | 29 | 25/4 | 51 (23–63) | 1.2 (0.3–2.4) | na | na |